Connect with us

National

Antigenic “supersite” could improve design of COVID-19 vaccines – News-Medical.Net

Researchers in the United States have defined an antigenic “supersite” within the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could…

Published

on

post featured image

Researchers in the United States have defined an antigenic “supersite” within the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could have important implications for the design of vaccines to protect against coronavirus disease 2019 (COVID-19).
The site was identified on the N-terminal domain (NTD) of the viral spike protein – the main structure the virus uses to bind and infect host cells.
The team – from Columbia University and the National Institute of Allergy and Infectious…

Click here to view the original article.